Cited by 134Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatmentReceptor Mechanisms and Signaling

On the supersensitivity of dopamine receptors, induced by neuroleptics

Christensen, A. V., Fjalland, B., Nielsen, I. M�ller·1976·Psychopharmacology

Abstract

Different neuroleptics caused dopamine receptor blockade (antagonism against methylphenidate-induced compulsive gnawing) for varying lengths of time. When the receptor blockade had expired, supersensitivity to dopamine agonists (occurrence of apomorphine-induced compulsive gnawing and enhancement of methylphenidate-induced gnawing) developed and persisted for varying periods of time. The degree and duration of supersensitivity was related to the degree and duration of the preceding receptor blockade. Inhibition of catecholamine or 5-HT synthesis had no influence on development of supersensitivity. Stimulation with a dopamine agonist, apomorphine, during the period of the development of supersensitivity did not modify the enhanced receptor supersensitivity. A cholinergic-dopaminergic balance was shown to be involved in the manifestation of compulsive behavior during the supersensitivity phase. Tolerance to the dopamine antagonistic effect of a neuroleptic also developed after a single neuroleptic treatment, most likely due to increased sensitivity of the receptors for the dopamine agonist. It is concluded, that the dopamine receptor blockade induced by a single dose of a neuroleptic agent is a dynamic phenomenon which in the course of time is replaced by an increased sensitivity of the receptors to dopamine agonists. Noradrenergic or 5-HT neuron systems do not seem to be involved in the neuroleptic-induced supersensitivity, whereas a dopaminergic-cholinergic balance is operative in the supersensitivity situation.

Integrity signals

Registry

Crossref · 10.1007/bf00423298

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The use of ketamine in psychiatry is at risk of replicating the 2016 opioid US epidemic abuse with the risk to induce neurotoxicity, which might be associated with persistent post-withdrawal disorders.

    “In view of the inevitable decay of the response to ketamine due to pharmacological tolerance [148] and its possible benefit as maintenance therapy in treatment-resistant depression [142], and considering that some clinicians use ketamine formulations for chronic use despite the alarm regarding 'the rapid proliferation of off-label ketamine administration in the absence of evidence of”

The citation lists haven’t been fetched yet

References 28 · Cited by 134

Authors
Christensen, A. V., Fjalland, B., & Nielsen, I. M.
Affiliations
Lundbeck (Denmark) (DK)
Venue
Psychopharmacology
Published
1976
Volume
48
Issue
1
Pages
1-6
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2025081012
Cited by
134
References
28
Citations by year
2024: 1 · 2020: 1 · 2019: 1 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
FWCI
4.07
Type
journal article
Language
en
Open access
closed
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
dopamine receptor supersensitivity, antipsychotic drugs, dopamine receptor blockade, dopamine agonists, apomorphine, methylphenidate, compulsive behavior, catecholamine synthesis inhibition, serotonin synthesis inhibition
MeSH terms
Animals, Apomorphine, Dopamine, Drug Tolerance, Humans, Male, Methylphenidate, Receptors, Drug, Stereotyped Behavior, Tranquilizing Agents, Neurotransmitter Agents, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review